India’s first intranasal Covid vaccine by Bharat Biotech received approval from the Drug Controller General of India (DCGI) for primary immunization against the injection for people above the age of 18. It is India’s first nasal vaccine for COVID-19. The Union Minister of Health and Family Welfare Mansukh Mandaviya termed the vaccine a ‘Big Boost’ to India’s fight against COVID-19.
Bank Maha Pack includes Live Batches, Test Series, Video Lectures & eBooks
Bharat Biotech International Limited (BBIL), is a global leader in vaccine innovation and developer of vaccines for infectious diseases. The BBIL announced that the development of the Intranasal COVID vaccine (BBV154), has been approved for restricted use in an emergency. The iNCOVACC, is a recombinant replication-deficient adenovirus vectored vaccine with a pre-fusion stabilized spike protein. This vaccine was evaluated in phases I, II, and III, clinical trials with successful results. The vaccine was formulated to allow Intranasal delivery through nasal drops. It is designed to be cost-effective in low and middle-income countries.
August 15, 1947, is considered one of the most significant days in the history of…
The Mountbatten Plan or the 3rd June Plan was proposed by Viceroy Lord Louis Mountbatten…
The Quit India Movement, which started on August 8, 1942, was probably one of the…
The 1946 mutiny of the Royal Indian Navy (RIN) was one of the last major…
The Indian National Army (INA), or Azad Hind Fauj, emerged as one of the most…
Gallantry Medals have been awarded to 301 members of the Police Force and Fire Services…